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Hashimoto Encephalopathy Mimicking Acute 
Ischemic Stroke: Perfusion-Weighted 
Magnetic Resonance Imaging
Dear Editor, 
A 61-year-old woman presented with sudden-onset left hemianopia. She had a history of 
hypertension but no other remarkable medical history, including thyroid disease. The find-
ings of the initial brain computed tomography (CT) were normal, and CT angiography 
showed no cerebral arterial occlusive lesion. Intravenous tissue plasminogen activator (tPA) 
was administered at 3 hours after symptom onset due to the impression of an infarction in 
the right posterior cerebral arterial territory. The visual symptom was not improved after 
tPA use. Brain magnetic resonance imaging (MRI) performed 6.5 hours after symptom on-
set showed no acute ischemic lesion, but perfusion-weighted MRI showed perfusion delay at 
the right parieto-occipital lobe, which was compatible with her visual symptom (Fig. 1A and 
B). Magnetic resonance (MR) angiography revealed no remarkable stenosis or occlusion 
(Fig. 1C). A visual field test showed left homonymous hemianopia (Fig. 1D, upper panel). 
We prescribed an antiplatelet agent, and the patient was discharged with her remaining visual 
symptom. 
Ten days after discharge she was readmitted due to right-sided hypesthesia and mental 
confusion. Hemianopsia was also detected in a follow-up visual field test. Brain MRI showed 
no ischemic lesion, and MR angiography findings were normal (Fig. 1E). The findings of a ce-
rebrospinal fluid examination (160 mmH2O opening pressure, 2 red blood cells/mL, 0 white 
blood cell/mL, 56.6 mg/dL protein, and 62 mg/dL glucose) and other laboratory tests were 
unremarkable. Although the findings of a thyroid function test (TFT) were normal [79.5 
ng/dL T3 (normal: 71–161 ng/dL), 1.3 ng/dL free T4 (normal: 0.8–1.7), and 1.89 µIU/mL 
thyroid-stimulating hormone (normal: 0.86–4.69 µIU/mL)], both antithyroglobulin anti-
body [138.5 IU/mL (normal: 10–124.2 IU/mL)] and antithyroid peroxidase antibody [126.0 
IU/mL (normal: 5–13.6 IU/mL)] were elevated. The suspicion of Hashimoto encephalopa-
thy resulted in corticosteroid therapy being started, which gradually improved her neuro-
logical symptoms. A visual field test performed after completing steroid therapy showed no 
visual field defect (Fig. 1D, lower panel).
Hashimoto encephalopathy has been described as a syndrome of encephalopathy and 
high serum antithyroid antibody concentrations that responds to glucocorticoid therapy.1 
Although it presents with various clinical manifestations, two subtypes have been previous-
ly proposed: a vasculitic type and a diffuse progressive type.2 Several pathogenic mechanisms 
underlying Hashimoto encephalopathy have been proposed: 1) autoimmune-mediated cere-
bral vasculitis, with or without immune complex deposition and 2) an antineuronal anti-
body-mediated mechanism.2-4 Brain single-photon-emission CT and positron-emission to-
mography scans have revealed perfusion abnormalities in several cases: either focal or global 
hypoperfusions.1,5-7 However, there has been no report of a perfusion delay in brain MRI dur-
Bang-Hoon Choa 
Kyeongyeol Cheona 
Kyung-Yul Leea,b
a Department of Neurology, 
Gangnam Severance Hospital, 
Yonsei University College of Medicine, 
Seoul, Korea
b Severance Institute for Vascular and 
Metabolic Research, Yonsei University 
College of Medicine, Seoul, Korea
pISSN 1738-6586 / eISSN 2005-5013   /   J Clin Neurol 2018;14(4):586-587   /   https://doi.org/10.3988/jcn.2018.14.4.586
Received May 18, 2018
Revised July 2, 2018
Accepted July 2, 2018
Correspondence
Kyung-Yul Lee, MD, PhD
Department of Neurology, 
Gangnam Severance Hospital, 
Yonsei University College of Medicine, 
211 Eonju-ro, Gangnam-gu, 
Seoul 06273, Korea
Tel    +82-2-2019-3325
Fax   +82-2-3462-5904
E-mail     kylee@yuhs.ac
cc  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Com-
mercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original work is properly cited.
LETTER TO THE EDITOR
www.thejcn.com  587
Cho BH et al. JCN
ing the hyperacute period of cerebral symptoms. In the pres-
ent case we performed perfusion-weighted MRI several hours 
after the onset of cerebral symptoms, which resulted in the 
perfusion delay being misinterpreted as a true ischemic stroke 
lesion. The absence of a diffusion-restriction lesion in two se-
rial brain MRI scans helped to rule out ischemic stroke as a 
cause of the neurological symptom. With suspicion of other 
etiologies of cerebral symptoms, an antithyroid antibody test 
was performed, for which the results were abnormal. In 
agreement with the present case, normal TFT results have 
been reported in 22% of patients with Hashimoto encepha-
lopathy.1 We speculated that the neurological sign in the 
present patient resulted from a vasculitic lesion of the brain, 
based on the relatively abrupt onset of the neurological symp-
tom and the focal hypoperfused cortical regions.
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Fig. 1. Brain MRI and visual field examination of the patient. A: Initial brain diffusion-weighted MRI shows no acute ischemic lesion. B: The mean 
transit time is delayed in the right parieto-occipital lobe in perfusion-weighted MRI. C: Magnetic resonance angiography shows that there is no sig-
nificant steno-occlusive lesion in the posterior cerebral artery. D: A left homonymous field defect is noted in the initial visual field examination (upper 
panel), and this is normalized after steroid therapy (lower panel). E: Follow-up MRI shows no ischemic lesions. MRI: magnetic resonance imaging.
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